COVID-19 pandemic The Medicines and Healthcare products Regulatory Agency approves the country's first monoclonal antibody cocktail drug (Ronapreve) developed by Regeneron and Roche to treat severe COVID-19 patients in the United Kingdom. UK approves Regeneron/Roche antibody cocktail for COVID-19 © Euronews Sources: Euronews
